CIC and Parkwalk have returned to back patient-focused genomic analysis developer Congenica, bringing its funding total to $85m.

Congenica, a UK-based patient genomic testing service provider based on research from Wellcome Sanger Institute and the UK’s National Health Service (NHS), closed a £39m ($50m) series C round on Friday featuring Cambridge Innovation Capital (CIC), the VC investor focused on the Cambridge, UK ecosystem. The round was co-led by internet group Tencent and insurance…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.